vs

Side-by-side financial comparison of LIVEPERSON INC (LPSN) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $59.3M, roughly 1.6× LIVEPERSON INC). Vericel Corp runs the higher net margin — 25.0% vs -77.8%, a 102.8% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -19.0%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-12.0M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -16.6%).

LivePerson is a global technology company that develops conversational commerce and AI software.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

LPSN vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.6× larger
VCEL
$92.9M
$59.3M
LPSN
Growing faster (revenue YoY)
VCEL
VCEL
+42.3% gap
VCEL
23.3%
-19.0%
LPSN
Higher net margin
VCEL
VCEL
102.8% more per $
VCEL
25.0%
-77.8%
LPSN
More free cash flow
VCEL
VCEL
$24.8M more FCF
VCEL
$12.8M
$-12.0M
LPSN
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LPSN
LPSN
VCEL
VCEL
Revenue
$59.3M
$92.9M
Net Profit
$-46.1M
$23.2M
Gross Margin
73.2%
78.7%
Operating Margin
-68.7%
24.1%
Net Margin
-77.8%
25.0%
Revenue YoY
-19.0%
23.3%
Net Profit YoY
58.9%
17.3%
EPS (diluted)
$-9.22
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPSN
LPSN
VCEL
VCEL
Q4 25
$59.3M
$92.9M
Q3 25
$60.2M
$67.5M
Q2 25
$59.6M
$63.2M
Q1 25
$64.7M
$52.6M
Q4 24
$73.2M
$75.4M
Q3 24
$74.2M
$57.9M
Q2 24
$79.9M
$52.7M
Q1 24
$85.1M
$51.3M
Net Profit
LPSN
LPSN
VCEL
VCEL
Q4 25
$-46.1M
$23.2M
Q3 25
$8.7M
$5.1M
Q2 25
$-15.7M
$-553.0K
Q1 25
$-14.1M
$-11.2M
Q4 24
$-112.1M
$19.8M
Q3 24
$-28.3M
$-901.0K
Q2 24
$41.8M
$-4.7M
Q1 24
$-35.6M
$-3.9M
Gross Margin
LPSN
LPSN
VCEL
VCEL
Q4 25
73.2%
78.7%
Q3 25
71.4%
73.5%
Q2 25
69.7%
73.7%
Q1 25
71.8%
69.0%
Q4 24
77.4%
77.6%
Q3 24
73.1%
71.9%
Q2 24
79.4%
69.5%
Q1 24
71.3%
68.9%
Operating Margin
LPSN
LPSN
VCEL
VCEL
Q4 25
-68.7%
24.1%
Q3 25
-24.2%
5.1%
Q2 25
-10.8%
-3.2%
Q1 25
-26.2%
-24.3%
Q4 24
-138.0%
24.5%
Q3 24
-21.6%
-4.3%
Q2 24
-37.3%
-11.5%
Q1 24
-42.7%
-10.7%
Net Margin
LPSN
LPSN
VCEL
VCEL
Q4 25
-77.8%
25.0%
Q3 25
14.5%
7.5%
Q2 25
-26.4%
-0.9%
Q1 25
-21.8%
-21.4%
Q4 24
-153.2%
26.3%
Q3 24
-38.1%
-1.6%
Q2 24
52.3%
-8.9%
Q1 24
-41.8%
-7.5%
EPS (diluted)
LPSN
LPSN
VCEL
VCEL
Q4 25
$-9.22
$0.46
Q3 25
$-2.76
$0.10
Q2 25
$-0.17
$-0.01
Q1 25
$-0.24
$-0.23
Q4 24
$-17.23
$0.40
Q3 24
$-4.74
$-0.02
Q2 24
$-0.33
$-0.10
Q1 24
$-0.40
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPSN
LPSN
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$95.0M
$137.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-44.5M
$354.6M
Total Assets
$454.7M
$488.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPSN
LPSN
VCEL
VCEL
Q4 25
$95.0M
$137.5M
Q3 25
$106.7M
$135.4M
Q2 25
$162.0M
$116.9M
Q1 25
$176.3M
$112.9M
Q4 24
$183.2M
$116.2M
Q3 24
$142.1M
$101.7M
Q2 24
$146.0M
$102.5M
Q1 24
$127.1M
$110.6M
Total Debt
LPSN
LPSN
VCEL
VCEL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$512.1M
Stockholders' Equity
LPSN
LPSN
VCEL
VCEL
Q4 25
$-44.5M
$354.6M
Q3 25
$-22.1M
$321.9M
Q2 25
$-82.4M
$306.8M
Q1 25
$-74.9M
$295.5M
Q4 24
$-67.3M
$292.0M
Q3 24
$45.9M
$257.5M
Q2 24
$66.6M
$243.0M
Q1 24
$19.2M
$233.9M
Total Assets
LPSN
LPSN
VCEL
VCEL
Q4 25
$454.7M
$488.0M
Q3 25
$511.4M
$453.3M
Q2 25
$604.2M
$435.6M
Q1 25
$596.2M
$424.6M
Q4 24
$607.8M
$432.7M
Q3 24
$692.0M
$390.4M
Q2 24
$703.8M
$376.8M
Q1 24
$724.7M
$356.7M
Debt / Equity
LPSN
LPSN
VCEL
VCEL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPSN
LPSN
VCEL
VCEL
Operating Cash FlowLast quarter
$-9.7M
$15.0M
Free Cash FlowOCF − Capex
$-12.0M
$12.8M
FCF MarginFCF / Revenue
-20.2%
13.8%
Capex IntensityCapex / Revenue
3.9%
2.4%
Cash ConversionOCF / Net Profit
0.65×
TTM Free Cash FlowTrailing 4 quarters
$-42.5M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPSN
LPSN
VCEL
VCEL
Q4 25
$-9.7M
$15.0M
Q3 25
$-6.0M
$22.1M
Q2 25
$-11.7M
$8.2M
Q1 25
$-3.1M
$6.6M
Q4 24
$-3.1M
$22.2M
Q3 24
$4.8M
$10.2M
Q2 24
$-17.9M
$18.5M
Q1 24
$1.1M
$7.2M
Free Cash Flow
LPSN
LPSN
VCEL
VCEL
Q4 25
$-12.0M
$12.8M
Q3 25
$-8.9M
$19.5M
Q2 25
$-14.8M
$81.0K
Q1 25
$-6.9M
$-7.6M
Q4 24
$-6.8M
$8.5M
Q3 24
$-230.0K
$-9.2M
Q2 24
$-22.9M
$1.8M
Q1 24
$-10.4M
$-6.8M
FCF Margin
LPSN
LPSN
VCEL
VCEL
Q4 25
-20.2%
13.8%
Q3 25
-14.8%
28.8%
Q2 25
-24.9%
0.1%
Q1 25
-10.6%
-14.5%
Q4 24
-9.2%
11.2%
Q3 24
-0.3%
-15.9%
Q2 24
-28.7%
3.4%
Q1 24
-12.2%
-13.3%
Capex Intensity
LPSN
LPSN
VCEL
VCEL
Q4 25
3.9%
2.4%
Q3 25
4.8%
3.9%
Q2 25
5.3%
12.9%
Q1 25
5.8%
27.0%
Q4 24
5.0%
18.3%
Q3 24
6.8%
33.5%
Q2 24
6.2%
31.8%
Q1 24
13.5%
27.3%
Cash Conversion
LPSN
LPSN
VCEL
VCEL
Q4 25
0.65×
Q3 25
-0.69×
4.35×
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons